Filing Details

Accession Number:
0001209191-18-061113
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-06 08:31:35
Reporting Period:
2018-12-03
Accepted Time:
2018-12-06 08:31:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1008848 Acorda Therapeutics Inc ACOR Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1360928 M Lauren Sabella 420 Saw Mill River Road
Ardsley NY 10502
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-12-03 1,072 $20.20 5,687 No 4 S Direct
Common Stock Disposition 2018-12-03 4,119 $20.66 1,568 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Sales pursuant to a 10b5-1 plan. These sales are primarily intended to cover the tax liability resulting from restricted stock vesting.
  2. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $20.0600 to $20.2500 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. Sales pursuant to a 10b5-1 plan.
  4. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $20.2500 to $20.7900 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.